Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyApar Kishor Ganti, Miranda Hughes, Billy W. Loo et al.|Journal of the National Comprehensive Cancer Network|2021Cited by 459
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 StudyMyung‐Ju Ahn, Jaafar Bennouna, Kentaro Tanaka et al.|Journal of Clinical Oncology|2024Cited by 177
First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2–Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non–Small-Cell Lung Cancer: TROPION-PanTumor01Toshio Shimizu, Rebecca S. Heist, Jon Greenberg et al.|Journal of Clinical Oncology|2023Cited by 168
The expanding capability and clinical relevance of molecular diagnostic technology to identify and evaluate EGFR mutations in advanced/metastatic NSCLCParth Shah, Nicola Normanno, Jacob Sands|Lung Cancer|2021Cited by 8
Single-day HER2neu amplification assessment using chip-based digital PCR in formalin-fixed paraffin-embedded breast carcinoma tissueParth Shah, Jacob Sands, Shiva Murarka et al.|Breast Cancer Targets and Therapy|2018Cited by 5